Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension

Bauer JH, Brooks CS (1979) The long term effect of propranolol therapy on renal function. Am J Med 66: 405?410

Warren SE, O'Connor DT, Cohen IM, Mitas JA (1981) Renal hemodynamic changes during long-term antihypertensive therapy. Clin Pharmacol Ther 29: 310?317

Wilkinson R, Stevens IM, Pickering M, Robson V, Hawkins T, Kerr DN, Harry JD (1980) A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension. Br J Clin Pharmacol 10: 51?59

Wainer E, Boner G, Rosenfeld JB (1980) Effects of pindolol on renal function. Clin Pharmacol Ther 28: 575?580

Boner G, Wainer E, Rosenfeld JB (1982) Effects of pindolol on renal function. II. Effects of intravenous and prolonged oral dosing. Clin Pharmacol Ther 32: 423?427

Malini PL, Strocchi E, Negroni S, Ambrosioni E, Magnani B (1982) Renal haemodynamics after chronic treatment with labetalol and propranolol. Br J Clin Pharmacol 13 [Suppl 1]: 123S-126S

Larsen JS, Pedersen EB (1980) Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension. Eur J Clin Pharmacol 18: 135?139

Sybertz EJ, Sabin DX, Pula KK, Vliet GV, Glennon J, Gold EH, Baum T (1981) Alpha-beta-adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927. J Pharmacol Exp Ther 218: 435?443

Baum T, Watkins RW, Sybertz EJ, Bemulapalli S, Pula KK, Eynon E, Nelson S, Bliet GV, Glennon J, Moran RM (1981) Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer of labetalol. J Pharmacol Exp Ther 218: 444?452

Baba T, Murabayashi S, Aoyagi K, Ishizaki T (1988) Effects of dilevalol, R,R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension. Eur J Clin Pharmacol 35: 9?15

Yabuuchi Y, Kinoshita D (1974) Cardiovascular studies of 5-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a new potent ?-adrenergic blocking agent. Jpn J Pharmacol 24: 853?861

Hiramori N, Ishimori T, Taira N (1979) A further study on anti-hypertensive action of ?-adrenoceptor blocking agents in conscious, renal hypertensive dogs. Arch Int Pharmacodyn Ther 242: 115?127

Ishizaki T, Ohnishi A, Sasaki T, Chiba K, Suganuma T, Kushida K (1983) Pharmacokinetics and absolute bioavailability of carteolol, a new ?-adrenertic blocking agent. Eur J Clin Pharmacol 25: 95?101

Tabei K, Furuya H, Asano Y, Hosoda S (1989) Effect of carteolol on renal function in healthy subjects and patients with hypertension. Eur J Clin Pharmacol 36: 83?86

Baba T, Boku A, Ishizaki T, Sonne K, Takebe K (1986) Renal effects of nicardipine in patients with mild-to-moderate essential hypertension. Am Heart J 111: 552?557

Gomez DM (1951) Evaluation of renal resistance with specific reference to change in essential hypertension. J Clin Invest 30: 1143?1155

Haber E, Koerner T, Page LB, Klinman B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29: 1349?1355

Ogihara T, Iinuma K, Nishi K, Arakawa Y, Takagi A, Kurata K, Miyai K, Kumahara Y (1977) A non-chromatographic non-extraction radioimmunoassay for serum aldosterone. J Clin Endocrinol Metab 45: 726?731

Mercier DE, Feld RD, Witte DL (1978) Comparison of dewpoint and freezing point osmometry. Am J Med Technol 44: 1066?1069

Cook ME, Clifton GG, Poland MP, Flamenbaum W, Wallin JD (1986) Effects of dilevalol and atenolol on renal function and haemodynamics of patients with mild to moderate hypertension. J Hypertens 4: S504-S506

Tsukiyama H, Otsuka K, Higuma K (1982) Effect of ?-adrenoceptor antagonists on central haemodynamics in essential hypertension. Br J Clin Pharmacol 13 [Suppl 2]: 269S-278S

O'Connor DT, Preston RA (1982) Urinary kallikrein activity, renal hemodynamics, and electrolyte handling during chronic beta blockade with propranolol in hypertension. Hypertension 4: 742?749

Textor SC, Fouad FM, Bravo EL, Tarazi RC, Vidt DG, Gifford RW (1982) Redistribution of cardiac output to the kidneys during oral nadolol administration. N Engl J Med 307: 602?605

Pedersen EB, Kornerup HJ (1976) Renal hemodynamics and plasma renin in patients with essential hypertension. Clin Sci Mol Med 50: 409?414